Medrisesp. z o.o.Status: Entity active
Research and experimental development in natural sciences and engineering
KRS: 0001031993 NIP: 7123453760 REGON: 52509490200000
Overview
Registry date
2023-04-19
Share capital
€1,100.64
Activity description
Medrise is a clinical research center established in 2023 by a group of experienced physicians. The company conducts clinical trials for new drugs and therapies targeting various diseases, including ulcerative colitis and Crohn's disease.
Registered address
Ul. Onyksowa 10, 20-582 Lublin, Poland
Website
medrise.plWebsite active
Email
[email protected]Email warning
Industry
Authorized Representatives
Ownership
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| NanosanguisS.A. | €123,868.94 | nanosanguis.com | |
| SatroecgS.A. | €108,594.53 | satroecg.pl | |
| Breeze Aircraftsp. z o.o. | €90,630.25 | breeze-energies.com | |
| Solvemed Groupsp. z o.o. | €77,682.21 | solvemedgroup.com/ | |
| IncellvuS.A. | €76,754.81 | incellvu.pl | |
| Tramagsp. z o.o. | €74,886.11 | orphinic.com | |
| DOTO Medicalsp. z o.o. | €59,692.04 | dotomedical.eu | |
| Bulletprovesp. z o.o. | €42,945.72 | bulletprove.com | |
| VET Cell Techsp. z o.o. | €36,222.22 | vetcelltech.com | |
| NanovelosS.A. | €21,006.26 | nanovelos.com |
Change history
| Event | Details | Date | |
|---|---|---|---|
| PKD change | Removed: 72.19.Z | 2026-03-23 |
Last updated: 2026-04-07